Francois Lifermann

Valenciennes, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 76 publications

Granulomatous systemic reaction mimicking sarcoidosis after hip arthroplasty: Diagnostic contribution of particle analysis.

Granulomatous systemic reaction mimicking sarcoidosis after hip arthroplasty: Diagnostic contribution of particle analysis.

Journal: Joint bone spine

Published: November 18, 2025

Granulomatous systemic reaction mimicking sarcoidosis after hip arthroplasty: diagnostic contribution of particle analysis.

Granulomatous systemic reaction mimicking sarcoidosis after hip arthroplasty: diagnostic contribution of particle analysis.

Journal: Joint bone spine

Published: November 18, 2025

Concordance between presenting features and relapse in granulomatosis with polyangiitis: implications for risk assessment and counselling.

Concordance between presenting features and relapse in granulomatosis with polyangiitis: implications for risk assessment and counselling.

Journal: RMD open

Published: October 12, 2025

Real-World Effectiveness and Safety of Fostamatinib in Difficult-to-Treat Immune Thrombocytopenia Patients. A Prospective, Multicenter Registry in France.

Real-World Effectiveness and Safety of Fostamatinib in Difficult-to-Treat Immune Thrombocytopenia Patients. A Prospective, Multicenter Registry in France.

Journal: American journal of hematology

Published: September 18, 2025

Thromboinflammation is associated with high thrombotic risk in patients with newly diagnosed myeloproliferative neoplasms.

Thromboinflammation is associated with high thrombotic risk in patients with newly diagnosed myeloproliferative neoplasms.

Journal: Leukemia

Published: August 20, 2025

Thromboinflammation is associated with high thrombotic risk in patients with newly diagnosed myeloproliferative neoplasms.

Thromboinflammation is associated with high thrombotic risk in patients with newly diagnosed myeloproliferative neoplasms.

Journal: Leukemia

Published: August 20, 2025

Cryopyrin-Associated Periodic Syndrome: Understanding Late Diagnosis in Adults from a French cohort.

Cryopyrin-Associated Periodic Syndrome: Understanding Late Diagnosis in Adults from a French cohort.

Journal: Journal of the American Academy of Dermatology

Published: August 11, 2025

Cryopyrin-associated periodic syndrome: Understanding late diagnosis in adults from a French cohort.

Cryopyrin-associated periodic syndrome: Understanding late diagnosis in adults from a French cohort.

Journal: Journal of the American Academy of Dermatology

Published: August 11, 2025

Polyarteritis nodosa associated with VEXAS syndrome and chronic myelomonocytic leukemia: a case-control study.

Polyarteritis nodosa associated with VEXAS syndrome and chronic myelomonocytic leukemia: a case-control study.

Journal: Rheumatology (Oxford, England)

Published: July 30, 2025

High-risk genomic consensus validation for patients with newly diagnosed multiple myeloma using next-generation sequencing.

High-risk genomic consensus validation for patients with newly diagnosed multiple myeloma using next-generation sequencing.

Journal: Blood

Published: May 15, 2025

Comparative Efficacy and Safety of Anakinra and Canakinumab in Patients With VEXAS Syndrome: An International Multicenter Study.

Comparative Efficacy and Safety of Anakinra and Canakinumab in Patients With VEXAS Syndrome: An International Multicenter Study.

Journal: Arthritis & rheumatology (Hoboken, N.J.)

Published: May 13, 2025

Real-World Evidence Supports Venetoclax as an Additional Option for Patients With t(11;14) Myeloma.

Real-World Evidence Supports Venetoclax as an Additional Option for Patients With t(11;14) Myeloma.

Journal: Clinical lymphoma, myeloma & leukemia

Published: March 26, 2025

Showing 1-12 of 76

Last Updated: 09/26/2026